4CPS-232 Comparative efficacy of risankizumab and guselkumab in moderate to severe plaque psoriasis
Rodriguez Goicoechea, M, Morales Rivero, B, Tejedor Tejada, E, Garcia Gomez, N, Barbero Hernández, MJ, Horno Ureña, F
Published in European journal of hospital pharmacy. Science and practice (23.03.2023)
Published in European journal of hospital pharmacy. Science and practice (23.03.2023)
Get full text
Journal Article
4CPS-156 Analysis of the effectiveness and safety of daratumumab in monotherapy in adult patients with relapsed refractory multiple myeloma
Alarcon-Payer, C, López López, AM, Gómez-De Rueda, F, Claramunt García, R, Barbero Hernández, MJ, Jiménez Morales, A
Published in European journal of hospital pharmacy. Science and practice (01.03.2020)
Published in European journal of hospital pharmacy. Science and practice (01.03.2020)
Get full text
Journal Article
4CPS-035 Persistence and safety of apremilast in psoriasis
López-López, AM, Claramunt García, R, Muñoz Cid, CL, Jerez Rojas, J, Jimenez López, Y, Perez Cano, E, Merino Almazan, M, Barbero Hernández, MJ
Published in European journal of hospital pharmacy. Science and practice (01.03.2019)
Published in European journal of hospital pharmacy. Science and practice (01.03.2019)
Get full text
Journal Article
4CPS-133 Safety and effectiveness of guselkumab on moderate to severe plaque psoriasis
Tejedor Tejada, E, Rodriguez Goicoechea, M, Moreno Lopez, A, Garcia Gomez, N, Barbero Hernandez, MJ, Horno Ureña, F
Published in European journal of hospital pharmacy. Science and practice (23.03.2023)
Published in European journal of hospital pharmacy. Science and practice (23.03.2023)
Get full text
Journal Article
DGI-058 Results of Using Tolvaptan
Cantudo Cuenca, MD, Acuña Vega, A, Dominguez Aguado, MB, Vargas Lorenzo, M, Del Moral Alcazar, C, Saldaña Soria, R, Cantudo Cuenca, R, Barbero Hernandez, MJ, Horno Ureña, F
Published in European journal of hospital pharmacy. Science and practice (01.03.2013)
Published in European journal of hospital pharmacy. Science and practice (01.03.2013)
Get full text
Journal Article
CP-151 Efficacy of 4, 12 and 24 weeks of treatment with ledipasvir/sofosbuvir, simeprevir, sofosbuvir, sofosbuvir/simeprevir and sofosbuvir/daclatasvir in patients with chronic hepatitis C virus
Ruiz, A Sánchez, Iglesias, M Barrales, Diaz, T Moreno, Hernandez, MJ Barbero, Almazan, M Merino, Soria, R Saldaña, Alcazar, C Del Moral, Medina, T Vilchez, Garcia, R Millan, Ureña, F Horno
Published in European journal of hospital pharmacy. Science and practice (01.03.2016)
Published in European journal of hospital pharmacy. Science and practice (01.03.2016)
Get full text
Journal Article